Efficacy and safety of a four-week treatment with budesonide/formoterol in patients with cough variant asthma: Open-label, randomized and parallel-group study compared with budesonide.
Not Applicable
- Conditions
- Cough variant asthma
- Registration Number
- JPRN-UMIN000004383
- Lead Sponsor
- Kyoto University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with hypersensitivity to Budesonide/formoterol. 2. Patients with other respiratory diseases. 3. Patients who take inhaled corticosteroids in the last 4 weeks 4. Patients who take long acting beta agonists in the last 5 days 5. Patients who take antiallergy agents and inhaled anticholinergic in the last 2 weeks 6. Patients who are given systemic corticosteroids in the last 30 days 7. Current smoker or ex-smoker of > 10 pack-years 8. Pregnancy or lactation 9. Patients who are considered inappropriate by physicians in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eicester Cough Questionnaire (LCQ) score
- Secondary Outcome Measures
Name Time Method 1. Exhaled nitric oxide concentrations 2. Indices of pulmonary function 3. Biomarkers of blood 4. Visual analogue scale score of cough 5. clinical symptoms